Jim Cramer says tap the brakes on comparing this year’s market to 2001 and 2008. Here is why

Jim Cramer says tap the brakes on comparing this year’s market to 2001 and 2008. Here is why


CNBC’s Jim Cramer said Tuesday he’s not taking seriously any comparisons drawn between the current stock market and the years 2001 and 2008, both of which saw steep sell-offs into year-end.

The “Mad Money” host acknowledged the S&P 500 has so far in 2022 followed a path that looks similar to its trajectory in 2001 and 2008. For example, it’s down roughly 13% year to date after mounting a comeback since mid-June, when it recorded its much-steeper lows of the year.

  • In 2008, the S&P 500 was down about 12% at this point and, in 2001, the broad U.S. stock index was lower by nearly 12%, Cramer said. In both years, the S&P 500 had bounced off earlier lows to get to where it was in late August.

However, Cramer said it’s incredibly important to go beneath the chart-level surface before concluding the stock market will end 2022 on a sour note. Not only is the U.S. economy at a much different part of the business cycle than in 2001 and 2008, but Cramer said “major destabilizing events” were primary drivers of the end-of-the-year slides.

“I just don’t see a parallel in this year. 2008, it was the reverberations from the Lehman Brothers collapse nearly bringing down the financial system. In 2001, of course, it was 9/11,” Cramer said.

Cramer said there is always a possibility of a so-called black swan event, noting there is inherent uncertainty about what lies ahead. “If something terrible happens on the scale of the Lehman Brothers collapse … then I would indeed change my mind,” he said.

However, he added, “here’s the bottom line: Unless something terrible comes out of nowhere, I’m feeling pretty sanguine about this market, because 2022 is not 2008 and not 2001.”

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More